Walleye Capital LLC Obs Eva Sa Transaction History

Walleye Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$2.01 - $5.05 $23,169 - $58,211	-11,527 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$1.89 - $2.55 $16,184 - $21,835	-8,563 Reduced 42.62%	11,527 $24,000
Q3 2020 Nov 16, 2020	BUY	$2.46 - $6.15 $49,421 - $123,553	20,090 New	20,090 $50,000
Q2 2020 Aug 14, 2020	SELL	$2.01 - $5.95 $192,220 - $569,010	-95,632 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.87 - $4.47 $16,889 - $40,373	9,032 Added 10.43%	95,632 $230,000
Q4 2019 Feb 14, 2020	BUY	$2.48 - $8.1 $214,768 - $701,460	86,600 New	86,600 $331,000

88K

Ticker OBSV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,499,200
Description
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.